Oncternal Therapeutics Inc (OQ:ONCT)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ONCT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Hale David F Indirect Ownership Warrants P - Open market or private purchase 8,706  
May 22/20 May 21/20 Hale David F Indirect Ownership Common Stock P - Open market or private purchase 17,412  
Mar 18/20 Mar 17/20 Breitmeyer James B Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -66,890  
Mar 18/20 Mar 17/20 Vincent Richard G Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -35,120  
Mar 18/20 Mar 17/20 Kaufmann Gunnar F. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -14,260  
Mar 18/20 Mar 17/20 Hsu Frank J. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -16,280  
Mar 18/20 Mar 17/20 Bilinsky Igor Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -12,690  
Mar 18/20 Mar 17/20 Aker Hazel M Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -11,080  
Jan 9/20 Jan 7/20 Breitmeyer James B Indirect Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -22,000  
Dec 23/19 Dec 18/19 Cho Man Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -30,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ONCT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 26th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Hale David F Indirect Ownership Warrants P - Open market or private purchase 8,706  
May 22/20 May 21/20 Hale David F Indirect Ownership Common Stock P - Open market or private purchase 17,412  
Mar 18/20 Mar 17/20 Breitmeyer James B Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -66,890  
Mar 18/20 Mar 17/20 Vincent Richard G Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -35,120  
Mar 18/20 Mar 17/20 Kaufmann Gunnar F. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -14,260  
Mar 18/20 Mar 17/20 Hsu Frank J. Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -16,280  
Mar 18/20 Mar 17/20 Bilinsky Igor Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -12,690  
Mar 18/20 Mar 17/20 Aker Hazel M Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -11,080  
Jan 9/20 Jan 7/20 Breitmeyer James B Indirect Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -22,000  
Dec 23/19 Dec 18/19 Cho Man Direct Ownership Stock Option A - Grant, award or other under Rule 16b-3(d) -30,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ONCT

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)